CVRx (CVRX) EBITDA Margin (QoQ) (2020 - 2026)
CVRx (CVRX) EBITDA Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | CVRx | 76.89 Mn | 12.31 Mn | 13.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -58.00 |
| Mar 31, 2026 | -1,255.00 |
| Dec 31, 2025 | 1,372.00 |
| Sep 30, 2025 | 2,228.00 |
| Jun 30, 2025 | 303.00 |
| Mar 31, 2025 | -4,185.00 |
| Dec 31, 2024 | 3,033.00 |
| Sep 30, 2024 | 2,105.00 |
| Jun 30, 2024 | 8,808.00 |
| Mar 31, 2024 | -12,097.00 |
| Dec 31, 2023 | 519.00 |
| Sep 30, 2023 | 3,306.00 |
| Jun 30, 2023 | 2,872.00 |
| Mar 31, 2023 | 754.00 |
| Dec 31, 2022 | 373.00 |
| Sep 30, 2022 | 5,523.00 |
| Jun 30, 2022 | 2,416.00 |
| Mar 31, 2022 | -284.00 |
| Dec 31, 2021 | -2,548.00 |
| Sep 30, 2021 | -3,314.00 |